Literature DB >> 24290359

Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription.

Scott D Ryan1, Nima Dolatabadi, Shing Fai Chan, Xiaofei Zhang, Mohd Waseem Akhtar, James Parker, Frank Soldner, Carmen R Sunico, Saumya Nagar, Maria Talantova, Brian Lee, Kevin Lopez, Anthony Nutter, Bing Shan, Elena Molokanova, Yaoyang Zhang, Xuemei Han, Tomohiro Nakamura, Eliezer Masliah, John R Yates, Nobuki Nakanishi, Aleksander Y Andreyev, Shu-ichi Okamoto, Rudolf Jaenisch, Rajesh Ambasudhan, Stuart A Lipton.   

Abstract

Parkinson's disease (PD) is characterized by loss of A9 dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). An association has been reported between PD and exposure to mitochondrial toxins, including environmental pesticides paraquat, maneb, and rotenone. Here, using a robust, patient-derived stem cell model of PD allowing comparison of A53T α-synuclein (α-syn) mutant cells and isogenic mutation-corrected controls, we identify mitochondrial toxin-induced perturbations in A53T α-syn A9 DA neurons (hNs). We report a pathway whereby basal and toxin-induced nitrosative/oxidative stress results in S-nitrosylation of transcription factor MEF2C in A53T hNs compared to corrected controls. This redox reaction inhibits the MEF2C-PGC1α transcriptional network, contributing to mitochondrial dysfunction and apoptotic cell death. Our data provide mechanistic insight into gene-environmental interaction (GxE) in the pathogenesis of PD. Furthermore, using small-molecule high-throughput screening, we identify the MEF2C-PGC1α pathway as a therapeutic target to combat PD.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24290359      PMCID: PMC4028128          DOI: 10.1016/j.cell.2013.11.009

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  55 in total

1.  S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.

Authors:  Takashi Uehara; Tomohiro Nakamura; Dongdong Yao; Zhong-Qing Shi; Zezong Gu; Yuliang Ma; Eliezer Masliah; Yasuyuki Nomura; Stuart A Lipton
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

2.  Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model.

Authors:  Erin H Norris; Kunihiro Uryu; Susan Leight; Benoit I Giasson; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Small-molecule activation of neuronal cell fate.

Authors:  Jay W Schneider; Zhengliang Gao; Shijie Li; Midhat Farooqi; Tie-Shan Tang; Ilya Bezprozvanny; Doug E Frantz; Jenny Hsieh
Journal:  Nat Chem Biol       Date:  2008-06-15       Impact factor: 15.040

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Toxicity of redox cycling pesticides in primary mesencephalic cultures.

Authors:  Dafna Bonneh-Barkay; William J Langston; Donato A Di Monte
Journal:  Antioxid Redox Signal       Date:  2005 May-Jun       Impact factor: 8.401

Review 6.  Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome.

Authors:  Carmen Gomez; Manuel J Bandez; Ana Navarro
Journal:  Front Biosci       Date:  2007-01-01

7.  Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation.

Authors:  G E Lyons; B K Micales; J Schwarz; J F Martin; E N Olson
Journal:  J Neurosci       Date:  1995-08       Impact factor: 6.167

8.  A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.

Authors:  S A Lipton; Y B Choi; Z H Pan; S Z Lei; H S Chen; N J Sucher; J Loscalzo; D J Singel; J S Stamler
Journal:  Nature       Date:  1993-08-12       Impact factor: 49.962

9.  Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells.

Authors:  Zhen Li; Scott R McKercher; Jiankun Cui; Zhiguo Nie; Walid Soussou; Amanda J Roberts; Tina Sallmen; Jeffrey H Lipton; Maria Talantova; Shu-ichi Okamoto; Stuart A Lipton
Journal:  J Neurosci       Date:  2008-06-25       Impact factor: 6.167

10.  Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo.

Authors:  Hao Li; Jonathan C Radford; Michael J Ragusa; Katherine L Shea; Scott R McKercher; Jeffrey D Zaremba; Walid Soussou; Zhiguo Nie; Yeon-Joo Kang; Nobuki Nakanishi; Shu-ichi Okamoto; Amanda J Roberts; John J Schwarz; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-01       Impact factor: 11.205

View more
  203 in total

1.  Direct Lineage Reprogramming Reveals Disease-Specific Phenotypes of Motor Neurons from Human ALS Patients.

Authors:  Meng-Lu Liu; Tong Zang; Chun-Li Zhang
Journal:  Cell Rep       Date:  2015-12-24       Impact factor: 9.423

2.  S-nitrosylation of fatty acid synthase regulates its activity through dimerization.

Authors:  Min Sik Choi; Ji-Yong Jung; Hyoung-June Kim; Mi Ra Ham; Tae Ryong Lee; Dong Wook Shin
Journal:  J Lipid Res       Date:  2016-02-05       Impact factor: 5.922

Review 3.  Understanding Parkinson's Disease through the Use of Cell Reprogramming.

Authors:  Rebecca Playne; Bronwen Connor
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

4.  Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.

Authors:  Christopher Czaniecki; Tammy Ryan; Morgan G Stykel; Jennifer Drolet; Juliane Heide; Ryan Hallam; Shalandra Wood; Carla Coackley; Keith Sherriff; Craig D C Bailey; Scott D Ryan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

Review 5.  Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.

Authors:  Fernanda Martins Lopes; Ivi Juliana Bristot; Leonardo Lisbôa da Motta; Richard B Parsons; Fabio Klamt
Journal:  Neuromolecular Med       Date:  2017-07-18       Impact factor: 3.843

Review 6.  Cell replacement therapy is the remedial solution for treating Parkinson's disease.

Authors:  Venkatesan Dhivya; Vellingiri Balachandar
Journal:  Stem Cell Investig       Date:  2017-06-30

Review 7.  Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.

Authors:  Caleb Pitcairn; Willayat Yousuf Wani; Joseph R Mazzulli
Journal:  Neurobiol Dis       Date:  2018-03-14       Impact factor: 5.996

Review 8.  Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.

Authors:  Joshua Kuruvilla; Andrew Octavian Sasmita; Anna Pick Kiong Ling
Journal:  Neurol Sci       Date:  2018-08-03       Impact factor: 3.307

9.  S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD.

Authors:  Elaine Pirie; Chang-Ki Oh; Xu Zhang; Xuemei Han; Piotr Cieplak; Henry R Scott; Amanda K Deal; Swagata Ghatak; Fernando J Martinez; Gene W Yeo; John R Yates; Tomohiro Nakamura; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

10.  Parkinson's Disease Master Regulators on Substantia Nigra and Frontal Cortex and Their Use for Drug Repositioning.

Authors:  D M Vargas; M A De Bastiani; R B Parsons; F Klamt
Journal:  Mol Neurobiol       Date:  2020-11-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.